FAM
LRMR icon

Fred Alger Management’s Larimar Therapeutics LRMR Stock Holding History

Fred Alger Management’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,267
Closed -$95.7K – 464
2026
Q1 		$95.7K Buy
+21,267
New +$85K ﹤0.01% 443
2025
Q1 		– Sell
-737,553
Closed -$2.85M – 453
2024
Q4 		$2.85M Sell
737,553
-49,035
-6% -$324K 0.01% 299
2024
Q3 		$5.15M Sell
786,588
-146,906
-16% -$1.18M 0.03% 236
2024
Q2 		$6.77M Sell
933,494
-54,439
-6% -$417K 0.03% 220
2024
Q1 		$7.5M Buy
987,933
+901,372
+1,041% +$7.02M 0.04% 221
2023
Q4 		$394K Sell
86,561
-29,708
-26% -$100K ﹤0.01% 406
2023
Q3 		$459K Buy
116,269
+21,331
+22% +$80.7K ﹤0.01% 385
2023
Q2 		$297K Sell
94,938
-190,797
-67% -$778K ﹤0.01% 420
2023
Q1 		$1.29M Buy
+285,735
New +$1.49M 0.01% 372
2022
Q1 		– Sell
-175,870
Closed -$1.9M – 535
2021
Q4 		$1.9M Hold
175,870
– – ﹤0.01% 360
2021
Q3 		$2.03M Buy
+175,870
New +$2.11M ﹤0.01% 347
2015
Q2 		– Sell
-1,271
Closed -$604K – 521
2015
Q1 		$604K Buy
+1,271
New +$603K ﹤0.01% 537

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Fred Alger Management's LRMR Position: Q2 2026 in Review

Fred Alger Management sold out of Larimar Therapeutics (LRMR) in Q2 2026, closing a stake of 21,267 shares — an estimated $95.7K sold.

Fred Alger Management first reported a position in LRMR in Q1 2015 and held it in 12 quarters. The position peaked at $7.5M in Q1 2024. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Fred Alger Management reported no remaining Larimar Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Fred Alger Management sold 21,267 Larimar Therapeutics shares in Q2 2026, an estimated $95.7K.
  • Fred Alger Management first reported a position in Larimar Therapeutics in Q1 2015 and held it in 12 quarters.
  • Fred Alger Management's Larimar Therapeutics position peaked at $7.5M in Q1 2024.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.